ArticleJournal of cell science2026
MOS is a key regulator of meiotic midbody assembly and prevents abnormal divisions in mouse eggs and their polar bodies.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitotic and meiotic midbody remnants: Divergent architectures with distinct clinical applications.Cell genomics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Mammalian female meiosis is uniquely regulated to produce a developmentally competent egg capable of supporting embryogenesis. During meiosis I, homologous chromosomes segregate, with half extruded into the first polar body. The egg then arrests at metaphase II and only resumes meiosis and extrudes the second polar body following fertilization. The MOS/MAPK signaling pathway is important for maintaining the metaphase II arrest; in Mos-/- mutants, a subset of eggs undergo spontaneous parthenogenetic activation and exhibit additional abnormal cell divisions. To further understand the cell cycle mis-regulation in activated Mos-/- eggs, we used time-lapse microscopy to monitor the abnormal divisions. We discovered that, following parthenogenetic activation, the first polar body can assemble a spindle, segregate chromosomes and divide with timings similar to anaphase II onset in the egg. This behavior contrasts with wild-type polar bodies, which do not divide and typically degenerate. We demonstrate that Mos-/- oocytes and polar bodies can exchange cytoplasm for a longer duration due to an extension of telophase I, likely allowing the transfer of cell cycle regulators between the two compartments. Further inspection revealed that Mos-/- oocytes have defective meiotic midbody assembly with most oocytes lacking a cap structure, which is needed to separate the oocyte and the polar body prior to abscission. We report that the polar bodies of Mos-/- eggs can re-enter the cell cycle and undergo additional aberrant divisions. These findings identify MOS as a crucial regulator of meiotic midbody formation and uncover a novel consequence of disrupted MOS/MAPK signaling - the potential for polar bodies to become mitotically active.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.